| 产品描述: | Tilfrinib (compound 4f) is a potent and selective Brk/PTK6 inhibitor with an IC50 value of 3.15 nM for Brk. Tilfrinib shows good anti-proliferative activity and has potential of anti-tumour |
| 靶点: |
IC50: 3.15 nM (Brk), PTK6 |
| 参考文献: |
1. Zhang Q, Liu S, et al. ETV4 mediated tumor-associated neutrophil recruitment promotes lymphangiogenesis and lymphatic metastasis of bladder cancer[J]. 2022. 2. Mahmoud KA, et al. Discovery of 4-anilino α-carbolines as novel Brk inhibitors. Bioorg Med Chem Lett. 2014 Apr 15;24(8):1948-51. |
| 溶解性: |
Soluble in DMSO |
| 保存条件: |
-80℃(运输条件:冰袋低温运输) |
| 配置溶液浓度参考: |
|
1mg |
5mg |
10mg |
| 1 mM |
3.632 ml |
18.162 ml |
36.323 ml |
| 5 mM |
0.726 ml |
3.632 ml |
7.265 ml |
| 10 mM |
0.363 ml |
1.816 ml |
3.632 ml |
| 50 mM |
0.073 ml |
0.363 ml |
0.726 ml |
|
| 注意: |
部分产品我司仅能提供部分信息,我司不保证所提供信息的权威性,仅供客户参考交流研究之用。 |